期刊文献+

miRNAlet7、Ras在非小细胞肺癌中的表达及其临床意义 被引量:1

Studies on the expressions and clinical significance of miRNAlet 7 and Ras in non-small cell lung cancer
原文传递
导出
摘要 目的探讨miRNAlet7(1et7)、Ras在非小细胞肺癌中的表达及临床病理学意义。方法利用原位杂交方法检测let7、免疫组化方法检测Ras在68例非小细胞肺癌(肺癌组)及20例癌旁正常肺组织(对照组)中的表达。结果let7在肺癌组中的阳性表达率(39.7%)低于对照组(75.0%)(P〈0.05)、Ras在肺癌组中的阳性表达率(66.2%)高于对照组(25.0%)(P〈0.01);let7阳性率与患者年龄、性别及肿瘤组织类型、分化程度、分期无关(P〉0.05),Ras阳性率与吸烟史、患者性别及肿瘤组织类型有关(P〈0.01),与肿瘤分化程度、淋巴结转移及临床分期无关(P〉0.05);let7与Ras在非小细胞肺癌组织中表达呈明显负相关(r=-0.627,P〈0.01);let7阳性表达组2年生存率明显优于阴性表达组(X2=4.84,P〈0.05);Ras阳性表达与阴性表达组2年生存率差异无统计学意义(P〉0.05)。结论let7的低表达、Ras的高表达参与了肺癌的发生发展,let7阳性表达与预后密切相关;Ras可协同参与肺癌的发生发展。 Objective To study the expressions of miRNAlet7 and Ras in non-small cell lung cancer (NSCLC), and their correlations with clinicopathological features and survival time. Methods In-situ hybridization was used to detect the expression of let7, and SP immunohistochemistry to measure HMGA2 in 68 NSCLC cases (group A) and 20 cases with normal lungs (group B). Results The positive rate of let7 in group A was lower than that in group B (39. 7% vs 63.2% ) ( P 〈0. 05) . The positive rate of Ras in group A was higher than that in group B (66.2% vs 25.0% ) ( P 〈0.01 ) . The positive rate of let7 was not related to the age, gender, histological type, cell differentiation, and clinical stages of cancer patients ( P 〉0. 05). The positive rate of Ras was related to smoking, sex, and histological type of cancer( P 〈 0. 01 ), and was not related to cell differentiation, lymphatic metastasis, and clinical stages of cancer ( P 〉 0. 05). There was an obvious negative correlation between let'/and Ras( r = -0.627, P 〈0. 01). The 2- year survival rate of let7-positive group was higher than that of the let 7-negative group ( X2 = 4. 84, P 〈 0. 05 ). No statistically significant difference was found between Ras-positive and -negative groups ( P 〉 0. 05 ). Conclusions The lower level of let7 expression, and high level of Ras expression have much to do with the carcinogenesis of NSCLC. The level of let7-positive expression is closely related to prognosis ; while Ras may act in cooperativity in the occurrence and development of NSCLC.
出处 《中国医师杂志》 CAS 2012年第7期881-884,888,共5页 Journal of Chinese Physician
基金 江苏省盐城市科技社会发展计划科研项目(YK2009103)
关键词 微RNAs/代谢 ras蛋白质类/代谢 非小细胞肺/病理学/代谢 MicroRNAs/metabolism Ras proteins/metabolism Carcinoma, non-small-cell lung/ pathology/metabolism
  • 相关文献

参考文献14

  • 1中国国家卫生部.(2010年中国卫生统计年鉴》目录,2010:268-307.
  • 2Kawasaki H, Altieri DC, Lu CD, et al. Inhibition of apoptosis by surviving predicts shorter survival rates in colorectal cancer. Canc- er Research,1998,58(22) :5071-5074.
  • 3苏琳,李冠华,李怀臣.miR-125b-1基因与人肺癌临床病理特征及其预后的关系[J].中国医师杂志,2008,10(10):1321-1324. 被引量:1
  • 4Motoyana K,Inoue H, Nakamura Y, et al. Clinical significance of high mobility group A2 in human gastric cancer and its relationship to let7 microRNA family. Clin Cancer Res, 2008,14 ( 8 ) : 2334- 2340.
  • 5Akao Y, Nakagawa Y, Naoe T. let-7 microRNA functions as a po- tential growth suppressor in human colon cancer cells. Biol Pharm Bull, 2006,29 ( 5 ) : 903 -906.
  • 6Sempere LF, Christensen M, Silahtaroglu A Altered MicroRNA expression confined to specific epithelial cell subpopulations in breast cancer. Cancer Res, 2007,67 ( 24 ) : 11612-11620.
  • 7Childs G, Fazzari M, Kung G, et al. Low-level expression of mi- croRNAs let-7d and miR-205 are prognostic markers of head and neck squamans cell carcinoma. Am J Pathol, 2009,174 ( 3 ) :736-745.
  • 8Yang N, Kaur S, Volinia S, et al. MicroRNA mieroarray identi- fies Let-Ti as a novel biomarker and therapeutic target in human epithelial ovarian cancer. Cancer Res, 2008,68 ( 24 ) : 10307- 10314.
  • 9Takamizawa J, Konishi H, Yanagisawa K, et al. Reduced ex- pression of the let-'/micmRNAs in human lung cancers in associ- ation with shortened postoperative survival. Cancer Res,2004,64 ( 11 ) :3753-3756.
  • 10赵洁,罗学锋,刘晓颖,伍玲.乳腺癌中组蛋白乙酰化与p21^WAF1的表达研究[J].中国医师杂志,2011,13(7):876-879. 被引量:1

二级参考文献31

  • 1王靖华,陈龙邦,黄文斌,李桂圆,孟奎,管晓翔,王晨.survivin和caspase-3在非小细胞肺癌中的表达及其与肿瘤细胞凋亡的关系[J].中国肺癌杂志,2005,8(5):435-439. 被引量:21
  • 2王锋,王水,宣卓琦,孙琳,陆辉.乳腺癌细胞中p53、C-erbB-2、p21^(WAF1)和CDK4的表达及临床意义[J].南京医科大学学报(自然科学版),2007,27(1):70-73. 被引量:8
  • 3Croce CM, Calin GA. miRNAs,Cancer,and Stem Cell Division. Cell, 2005,122( 1 ) :6-7.
  • 4Hammond SM. MicroRNAs as oncogenes. Curr Opin Genet Dev,2006,16 (1) :4-9.
  • 5Iorio M V, Ferracin M, Liu CG, et al. MicroRNA gene expression deregulation in human breast cancer. Cancer Res,2005, 65 (16) :7065-7070.
  • 6Kanazawa H, Ebina M, Ino-oka N, et al. Transition from squamous cell carcinoma to adenocarcinoma in adenosquamous carcinoma of the lung. Am J Path,2000,156:1289-1298.
  • 7Beder LB, Gunduz M, Ouchida M, et al. Genome-wide analyses on loss of heterozygosity in head and neck squamous cell carcinomas. Lab Invest ,2003,83:99-105.
  • 8Calin GA,Sevignani C,Dμmitru CD, et al. Hμman microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci USA,2004,101 (9) : 2999-3004.
  • 9Bracht J, Hunter S, Eachus R,et al. Trans-splicing and polyadenylation of let-7 microRNA primary transcripts. RNA,2004,10(10) :1586-1594.
  • 10Chuang C, Lin SH, Huang F, et al. Acetylation of RNA process- ing proteins and cell cycle proteins in motosis. Proteome Res, 2010, 9(9) :4554-4564.

共引文献8

同被引文献14

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部